The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 30 sources its claims cite is checked for support yet.
Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries.
Open accessAbstract
OBJECTIVE: Excess mortality from diseases and medical conditions (natural death) in persons with psychiatric disorders has been extensively reported. Even in the Nordic countries with well-developed welfare systems, register based studies find evidence of an excess mortality. In recent years, cardiac mortality and death by diseases of the circulatory system has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease. The aim of this study was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland. Furthermore, the aim was to examine and compare life expectancy among these patients. Cause specific Standardized Mortality Rates (SMRs) were calculated for each specific subgroup of mortality. Life expectancy was calculated using Wiesler's method. RESULTS: The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes. SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark. Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter. CONCLUSION: Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy. An evaluation of the reasons for these increased mortality rates should be prioritized when planning healthcare in the coming years.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In Denmark, Finland, and Sweden, people hospitalized with bipolar disorder or schizophrenia had 2- to 3-fold overall mortality and substantially reduced life expectancy compared with the general population. Mortality from diseases of the circulatory system was about 2-fold elevated in bipolar disorder and somewhat higher in schizophrenia, except among men in Denmark.
Key findings
- Among 39,375 persons with bipolar disorder and 66,088 with schizophrenia followed in 2000–2006, all-cause SMRs were 2.0–2.8 for bipolar disorder and 2.9–3.9 for schizophrenia; for example, men in Finland had SMR 2.8 for bipolar disorder and 3.3 for schizophrenia, while women in Finland had SMR 2.5 and 3.9, respectively.
- SMRs for diseases of the circulatory system (DCS) in bipolar disorder were approximately 2 in all countries and both sexes, with overall DCS SMRs ranging from 1.7 to 2.2. In schizophrenia, overall DCS SMRs ranged from 1.8 to 2.9 and were higher than in bipolar disorder except for men in Denmark (1.8 vs 2.0).
- Life expectancy at age 15 was 11 to 20 years shorter overall. In the table, differences for men were 12.7–19.8 years for bipolar disorder and 17.1–20.0 years for schizophrenia; for women, differences were 11.0–16.2 years for bipolar disorder and 15.6–16.9 years for schizophrenia.
- During 2000–2006, 2,960 of 5,436 deaths (54%) in bipolar disorder and 6,424 of 9,535 deaths (67%) in schizophrenia would not have occurred if mortality matched the general population; 781 and 1,770 of these excess deaths were from DCS, and the total avoidable deaths across both groups were 9,384 over seven years.
Methods
- Register-based cohort study in Denmark, Finland, and Sweden including all persons with a psychiatric hospitalization with a main diagnosis of bipolar disorder or schizophrenia. Follow-up began on 1 January 2000 or the 15th birthday, whichever came last, and ended on 1 January 2007 or death, whichever came first.
- Diagnoses came from national psychiatric/hospital discharge registers using ICD-8, ICD-9, or ICD-10 as relevant; deaths came from national cause-of-death registers. Schizoaffective disorder was excluded from both diagnostic groups.
- Cause-specific SMRs were age-standardized to the Nordic standard population in 2000 with 95% confidence intervals; life expectancy at 15 was calculated using Wiesler’s method with one-year age stratification; avoidable deaths were calculated as N*((SMR−1)/SMR).
Limitations
- The paper states that schizoaffective disorder was excluded, that ICD diagnoses do not differentiate bipolar I from bipolar II disorder (so bipolar I may be overestimated), that antipsychotic treatment differences may partly explain cardiovascular mortality differences, and that Finland’s fragmented health care access may contribute to its higher SMRs.
- Evident from the text: the cohort includes only patients with a psychiatric hospitalization, so findings may not generalize to non-hospitalized or outpatient-treated patients.
- Evident from the text: register data lack individual confounders such as lifestyle, smoking, alcohol, exercise, and medication adherence; Swedish hospital data were incomplete before 1987, so case ascertainment relied on a 1987–1999 lookback.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
27 Own result · 25 Not checked yet · 7 Own interpretation · 3 Own method · 3 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The SMR for bipolar disorder for different subgroups of diseases of the circulatory system (DCS) was approximately 2 in all countries and both sexes, and thus lower than the all-cause SMRs, Table 1and 2.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes.”
- Also stated in: § Results · plain
“The SMR for bipolar disorder for different subgroups of diseases of the circulatory system (DCS) was approximately 2 in all countries and both sexes, and thus lower than the all-cause SMRs, Table 1and 2.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“this study show that persons with schizophrenia or bipolar disorder still have a substantially reduced life expectancy.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Conclusions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Apart from this difference the mortality rates and life expectancy are remarkably similar in the three countries.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparison between the Study Countries
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Persons with bipolar disorder in Denmark and Sweden had higher life expectancy than persons with schizophrenia.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even in the Nordic countries with well-developed welfare and public health systems this group of patients experiences an unacceptable high mortality.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Conclusions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter.”
- Also stated in: § Results · plain
“Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being 11 to 20 years shorter.”
- Also stated in: § Conclusion · plain
“Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Abstract > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In general SMR for mortality from external causes (accidents, suicide, and homicide) was very high (range from 4 to 10).”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“If no excess mortality from external causes was present the numbers was 865 and 1,322, respectively.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The number of deaths in all three countries that would not have occurred if persons with bipolar disorder or schizophrenia had not had an excess mortality from I00-I99 was 781 and 1,770, respectively.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 17
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“although men and women in Finland with bipolar disorder have a lower overall mortality measured by SMR than men and women with schizophrenia, the potential loss of living years are larger among persons with bipolar disorder.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparison between the Study Countries
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The SMRs for persons with schizophrenia, was even higher with a SMR for men equaling 3.3, 3.0 and 2.9 in Finland, Denmark, and Sweden, respectively, Table 1 and 2.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During the years 2000 to 2006 the number of deaths in all three countries that would not have occurred in the hypothetical situation that the individuals with a psychiatric disorder had the same mortality as the general population was 2,960 (out of 5,436 deaths, 54%) in the group of persons with bipolar disorder and 6,424 (out of 9,535 deaths, 67%) in the group of schizophrenic persons.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All-cause mortality was high among persons with bipolar disorder, resulting in a SMR for men in Finland equaling 2.8, in Denmark 2.2, and in Sweden 2.0.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SMR for DCS among persons with schizophrenia was also lower than overall SMRs in Denmark and Finland, but not in Sweden.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For women with schizophrenia the SMR was 3.9, 2.7 and 2.9 in Finland, Denmark, and Sweden, respectively.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The SMR for women was 2.5 in Finland, 2.3 in Sweden and 2.0 in Denmark.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the Nordic countries, women and men with severe mental disorders have an approximately 15 and 20 years shorter life expectancy, respectively, than the general population [8].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Introduction
What the sources say
- Not checked yetcites [8] Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM (2011) Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. bjp.bp.110.085100 [pii];10.1192/bjp.bp.110.085100 [doi]. source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“A study from Denmark showed that patients with bipolar affective disorder or schizophrenia still have an overall cardiac mortality that is higher than in the general population, and that the excess mortality tends to be even larger in the most recent calendar time period [12].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Introduction
What the sources say
- Not checked yetcites [12] TM Laursen, 2011, Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006, J Psychiatr Res source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Excess mortality from diseases and medical conditions in persons with psychiatric disorders has been extensively reported [1].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Introduction
What the sources say
- Not checked yetcites [1] EC Harris, 1998, Excess mortality of mental disorder, Br J Psychiatry source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The Swedish Cause of Death Register contains information about all deaths in Sweden and the coding error is estimated from a sample of deaths and was only 3% [20].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Methods > Assessment of Psychiatric Illness and Cause of Death
What the sources say
- Not checked yetcites [20] LA Johansson, 2000, Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics, Int J Epidemiol source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease [11].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Introduction
What the sources say
- Not checked yetcites [11] M Nordentoft, 2013, Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in denmark, Finland and sweden, Plos One source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Diseases of the circulatory system are the most common cause of death in the general population in Western countries [9], [10], including Denmark, Finland, and Sweden.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Introduction
What the sources say
- Not checked yetcites [9] Laursen TM (2006) A register based epidemiological description of risk factors and outcomes for major psychiatric disorders, focusing on a comparison between bipolar affective disorder and schizophrenia. PhD thesis. Universty of Aarhus.
- Not checked yetcites [10] CH Hennekens, 2005, Schizophrenia and increased risks of cardiovascular disease, Am Heart J source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“In a study including information from 20 million individuals from three Nordic countries with complete national coverage, and with more than 100,000 persons with bipolar disorder or schizophrenia”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion
plainn = 100,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The schizoaffective subgroup, often included in the schizophrenia group, with a generally more favourable outcome than schizophrenia, was not included in our analyses.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Reviews have found a huge reduction in life expectancy of approximately 10 to 20 years in persons with schizophrenia.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“On average the excess mortality rate in people with schizophrenia resulted in a SMR equaling 2–3 and a SMR for persons with bipolar disorder equaling a little less than two.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [31]–[41]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [43] CK Chang, 2011, Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London, PLoS One source
- Not checked yetcites [44] TM Laursen, 2011, Life expectancy among persons with schizophrenia or bipolar affective disorder, Schizophr Res source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the explanation is that e.g. Finnish men with bipolar disorder have a very high mortality rate in the age groups between 15 and 44 years: a person who dies at a young age contributes many years to the potential loss of living years, and thus this measure becomes high although SMRs are not that high.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparison between the Study Countries
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“And lastly, the risk of suicide is very high [40].”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“physical illnesses in persons with schizophrenia or bipolar disorder are apparently treated insufficiently or diagnosed too late”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Persons with schizophrenia and bipolar disorder constitute a vulnerable group of patients who need special attention.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Conclusions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This may create higher levels of health inequity in Finland than in Denmark or Sweden.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparison between the Study Countries
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Rests on an assumption: Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it shows that although schizophrenia and bipolar disorder are rare disorders, the extent of the increased mortality is a substantial public health problem that has not been addressed.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Preventing the High Mortality
plainn = 100,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“some antipsychotic medicine may have negative side effects, although no clear differences between different antipsychotics have been found”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Most studies find that cardiovascular disorder is the leading cause of death in both disorders.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [31]–[41]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The difference may be related to problems in health care access in Finland.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparison between the Study Countries
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Rests on an assumption: Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
In the paper
“persons with schizophrenia and bipolar disorder tended to have an unhealthy lifestyle especially regarding diet, smoking, alcohol, and exercise”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [40] TM Laursen, 2012, Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In a recent study from Stockholm County, around 30% of persons with bipolar disorder treated at a specialized affective disorder unit medicated with antipsychotics [42], while in schizophrenia almost none would be without antipsychotics, and also taking larger doses.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion > Comparisons with other Studies
What the sources say
- Not checked yetcites [42] M Adler, 2012, Symptoms and treatment of bipolar patients in Sweden, Int J Psychiatry Clin Pract source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries.
“The probability of getting a diagnosis of schizophrenia or bipolar disorder before the age of 15 is virtually zero in the Nordic countries, and thus the reason for starting follow-up at that time point in life.”
The authors state this as an assumption.
The mortality of the general population is an appropriate counterfactual for the mortality that patients with bipolar disorder or schizophrenia would have had in the absence of their psychiatric disorder.
“the hypothetical situation that the individuals with a psychiatric disorder had the same mortality as the general population”
“By reducing mortality in the group of persons with schizophrenia or bipolar disorder (approximately 100,000 persons) to the level of the general population”
The paper relies on this without support.
Health care access in Finland is compromised by a fragmented health system more dependent on employment status and income than in Denmark and Sweden.
“in Finland availability is compromised by a fragmented health system, where health care access is more dependent on employment status and income level.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, both disorders have severe negative consequences for social functioning, work ability, and lifespan.”
From Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Evidence suggests CVD is the leading cause of death in individuals with SMI.2,27,28”
From Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014 (2017) · cites this paper as [28]
In the citing paper
“Mental illness is broadly associated with poorer physical health outcomes; the severity of which is epitomised by a 15- to 20-year mortality gap between individuals with serious mental illness and the general population [104••, 105, 106].”
From Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety (2018) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
“Similarly, life expectancy among persons with bipolar disorder and schizophrenia was higher in Sweden than in the other two Nordic countries.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
“| Schizophrenia | 48.8 | 16.5 | 51.9 | 15.6 | 15.6 | 50.7 | 16.9 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
“| All causes of death | 2.2 (2.0–2.3) | 770 | 2.8 (2.5–3.0) | 485 | 2.0 (1.9–2.2) | 1097 |”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Discussion
“only men in Finland with schizophrenia had overlapping confidence intervals of the overall SMR with men with bipolar disorder.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Methods > Assessment of Psychiatric Illness and Cause of Death
“ischaemic heart disease (I20–25)”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Methods > Assessment of Psychiatric Illness and Cause of Death
“a miscellaneous group of Chapter I (I00-I20, I26-I59, I70-I99).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Overall DCS (I00-I99) | 1.7 (1.5–1.9) | 308 | 2.1 (1.7–2.4) | 121 | 1.8 (1.7–1.9) | 566 |”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
Reported 121 · recomputed 71
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
“SMR for DCS among persons with schizophrenia was also lower than overall SMRs in Denmark and Finland, but not in Sweden.”
§ Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries > Results
“| Overall DCS | 1.8 (1.6–2.1) | 294 | 2.9 (2.6–3.1) | 471 | 2.5 (2.3–2.7) | 783 |”
Citations
Cites
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Rothman, K. J., Greenland, S., & Lash, T. L. (1998) · Cited by 2,096
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
The Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589
- Statistical Models for Epidemiology
Broemeling, L. D. (2013) · Chapman & Hall/CRC eBooks · doi:10.1201/b15382-9 · Cited by 1,346
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120
Self-citationSchizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · cited 1×
“In recent years, cardiac mortality has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease [11].”
BackgroundSelf-citationChang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019590 · Cited by 714 · cited 1×
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
ResultMortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 1×
“Even in the Nordic countries with well-developed welfare systems, register based studies find continued evidence of an excess mortality [2–7].”
BackgroundSelf-citation
Research works printed but not linked: 4
- I Keskimäki, 1991, The accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register, International Journal of Health Sciences, 2, 15
- Clayton D, Hills M (1993) Statistical models in epidemiology. Oxford University.
- Breslow NE, Day NE (1987) Rates and Rate standardization. In: Heseltine E, editors. Statistical methods in cancer research. Lyon: Oxford University press. 48–82.
- Wiesler H (1954) Une me’ thode simple pour la construction de tables de mortalite’ abre’ ge’ es. Proceedings of the First World Population Conference, Rome,vol 4 United Nations, 1954.
Cited by
Sorted by citations
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Chesney, E., Goodwin, G. M., & Fazel, S. (2014) · World Psychiatry · doi:10.1002/wps.20128 · Cited by 2,115
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304
Self-citationExcess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Self-citationCorrell, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 758
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.202606 · Cited by 451
A systematic review and meta-analysis of premature mortality in bipolar affective disorder
Hayes, J. F., Miles, J., Walters, K., King, M., & Osborn, D. P. J. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12408 · Cited by 370
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 365
Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety
Kandola, A., Vancampfort, D., Herring, M., Rebar, A., Hallgren, M., Firth, J., & Stubbs, B. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0923-x · Cited by 291
Chan, J. K. N., Correll, C. U., Wong, C. S. M., Chu, R. S. T., Fung, V. S. C., Wong, G. H. S., Lei, J. H. C., & Chang, W. C. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102294 · Cited by 284
Severe Mental Illness and Cardiovascular Disease
Goldfarb, M., Binder, M. D., Detraux, J., Palo, K. E. D., Munir, H., Music, S., Piña, I. L., & Ringen, P. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.017 · Cited by 250
Life expectancy in bipolar disorder
Kessing, L. V., Vradi, E., & Andersen, P. K. (2015) · Bipolar Disorders · doi:10.1111/bdi.12296 · Cited by 230
Young, S. L., Taylor, M., & Lawrie, S. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114562090 · Cited by 212
Antipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208
Causes of decreased life expectancy over the life span in bipolar disorder
Kessing, L. V., Vradi, E., McIntyre, R. S., & Andersen, P. K. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.027 · Cited by 209
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Westman, J., Eriksson, S. V., Gissler, M., Hällgren, J., Prieto, M. L., Bobo, W. V., Frye, M. A., Erlinge, D., Alfredsson, L. S., & Ösby, U. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000166 · Cited by 171
Self-citationMedical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems
SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 160
Chan, J. K. N., Tong, C. C. H. Y., Wong, C. S. M., Chen, E. Y. H., & Chang, W. C. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.19 · Cited by 145
Oakley, P., Kisely, S. R., Baxter, A. J., Harris, M., Desoe, J., Dziouba, A., & Siskind, D. J. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.019 · Cited by 152
Hallyburton, A. (2022) · International Journal of Mental Health Nursing · doi:10.1111/inm.13034 · Cited by 159
Suvisaari, J., Keinänen, J., Eskelinen, S., & Mantere, O. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0704-4 · Cited by 123
Biazus, T. B., Beraldi, G. H., Tokeshi, L., Rotenberg, L. D. S., Dragioti, E., Carvalho, A. F., Solmi, M., & Lafer, B. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02109-9 · Cited by 133
Raben, A., Marshe, V. S., Chintoh, A. F., Gorbovskaya, I., Müller, D. J., & Hahn, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00741 · Cited by 117
Goldstein, B. I., Baune, B. T., Bond, D. J., Chen, P., Eyler, L. T., Fagiolini, A. M., Gomes, F. A., Hájek, T., Hatch, J. K., McElroy, S. L., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12921 · Cited by 116
Causes of mortality in schizophrenia: an updated review of European studies
Department of Psychiatry, W. M. U., Piotrowski, P., M. Gondek, T., Department of Psychiatry, W. M. U., Królicka-Deręgowska, A., Department of Psychiatry, W. M. U., Misiak, B., Department of Genetics, W. M. U., Adamowski, T., Department of Nervous System Diseases, F. O. H. S., et al. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.108 · Cited by 107
“- - Mittoux et al. 2013 Denmark register N/A 2002-2008 - 38.3 (18.0-84.6) -”
BackgroundResultInfluentialLomholt, L. H., Andersen, D. V., Sejrsgaard-Jacobsen, C., Øzdemir, C. M., Graff, C., Schjerning, O., Jensen, S. E., Straszek, S. P. V., Licht, R. W., Grøntved, S., et al. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-018-0140-x · Cited by 106
Excess medical comorbidity and mortality across the lifespan in schizophrenia.
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.020 · Cited by 103
Prieto, M. L., Barboza, A. B. C., Bobo, W. V., Roger, V. L., Bellivier, F., Leboyer, M., West, C. P., & Frye, M. A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12293 · Cited by 103
Is it time for immunopsychiatry in psychotic disorders?
Leboyer, M., Oliveira, J., Tamouza, R., & Groc, L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4266-1 · Cited by 98
Heiberg, I. H., Jacobsen, B. K., Nesvåg, R., Bramness, J. G., Reichborn‐Kjennerud, T., Næss, Ø., Ystrøm, E., Hultman, C. M., & Høye, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202028 · Cited by 94
Jakobsen, A. S., Speyer, H., Nørgaard, H. C. B., Karlsen, M., Hjorthøj, C. R., Krogh, J., Mors, O. N., Nordentoft, M., & Toft, U. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.016 · Cited by 92
Self-citationÖsby, U., Westman, J., Hällgren, J., & Gissler, M. (2016) · European Journal of Public Health · doi:10.1093/eurpub/ckv245 · Cited by 92
Self-citationExcess Mortality in Bipolar Disorders
Miller, C. J., & Bauer, M. S. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0499-z · Cited by 94
Hansen, P. S., Laursen, M. F., Grøntved, S., Straszek, S. P. V., Licht, R. W., & Nielsen, R. E. (2018) · Bipolar Disorders · doi:10.1111/bdi.12684 · Cited by 82
Nielsen, M. Ø., Rostrup, E., Wulff, S., Glenthoj, B. Y., & Ebdrup, B. H. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2582 · Cited by 76
Baxter, A. J., Harris, M., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163170 · Cited by 82
Kugathasan, P., Stubbs, B., Aagaard, J., Jensen, S. E., Laursen, T. M., & Nielsen, R. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13076 · Cited by 75
Self-citationToffol, E., Hätönen, T., Tanskanen, A. J., Lönnqvist, J. K., Wahlbeck, K., Joffe, G., Tiihonen, J., Haukka, J. K., & Partonen, T. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.055 · Cited by 75
Self-citationCardiovascular diseases among patients with schizophrenia
Azad, M. C., Shoesmith, W. D., Mamun, M. A., Abdullah, A. F., Naing, D. K. S., Phanindranath, M., & Turin, T. C. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.11.012 · Cited by 77
Cernea, S., Dima, L., Correll, C. U., & Manu, P. (2020) · Drugs · doi:10.1007/s40265-020-01393-x · Cited by 76
Scharf, D. M., Eberhart, N. K., Hackbarth, N. S., Horvitz-Lennon, M. V., Beckman, R., Han, B., Lovejoy, S. L., Pincus, H. A., & Burnam, M. A. (2014) · Rand health quarterly · doi:10.7249/rhq-04-03-06 · Cited by 73
Bioque, M., García‐Portilla, M. P., García‐Rizo, C., Cabrera, B., Lobo, A., González-Pinto, A. M., Díaz‐Caneja, C. M., Corripio, I., Vieta, E., Castro‐Fornieles, J., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.032 · Cited by 71
Webb, R. T., Lichtenstein, P., Larsson, H., Geddes, J. R., & Fazel, S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08899 · Cited by 70
Chan, J. K. N., Wong, C. S. M., Yung, N. C. L., Chen, E. Y. H., & Chang, W. C. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000305 · Cited by 67
Bodén, R., Molin, E., Jernberg, T., Kieler, H., Lindahl, B., & Sundström, J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12329 · Cited by 68
Deenik, J., Kruisdijk, F. R., Tenback, D. E., Braakman‐Jansen, A., Taal, E., Hopman-Rock, M., Beekman, A. T. F., Tak, E. C. P. M., Hendriksen, I. J. M., & van Harten, P. N. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1466-0 · Cited by 67
Croatto, G., Vancampfort, D., Miola, A., Olivola, M., Fiedorowicz, J. G., Firth, J., Alexinschi, O., Gaina, M. A., Makkai, V., Soares, F. C., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01770-w · Cited by 66
Scheewe, T. W., Jörg, F., Takken, T., Deenik, J., Vancampfort, D., BACKX, F. J. G., & Cahn, W. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00087 · Cited by 63
DNA Methylation and Schizophrenia: Current Literature and Future Perspective
Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 68
Coello, K., Vinberg, M., Knop, F. K., Pedersen, B. K., McIntyre, R. S., Kessing, L. V., & Munkholm, K. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0142-3 · Cited by 63
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Henkemans, O. B., Rosenbaum, S., Hendriksen, I. J. M., & van Harten, P. N. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4608-x · Cited by 60
Lithium treatment and cancer incidence in bipolar disorder
Martinsson, L., Westman, J., Hällgren, J., Ösby, U., & Backlund, L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12361 · Cited by 60
Self-citationHorsdal, H. T., Köhler‐Forsberg, O., Benros, M. E., & Gasse, C. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.04.012 · Cited by 62
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Rutters, F., Hendriksen, I. J. M., & van Harten, P. N. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.033 · Cited by 60
Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder
Bai, Y., Li, C., Tsai, S., Tu, P., Chen, M., & Su, T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1143-8 · Cited by 58
Higher mortality and years of potential life lost of suicide in patients with schizophrenia
Ko, Y. S., Tsai, H.-C., Chi, M. H., Su, C., Lee, I. H., Chen, P. S., Chen, K. C., & Yang, Y. K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.038 · Cited by 54
Fok, M. L.-Y., Stewart, R. J., Hayes, R. D., & Moran, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100979 · Cited by 54
Nordentoft, M., Plana‐Ripoll, O., & Laursen, T. M. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000697 · Cited by 52
Self-citationImpaired glucose metabolism in bipolar patients and response to mood stabilizer treatments
Steardo, L., Fabrazzo, M., Sampogna, G., Monteleone, A. M., D’Agostino, G., Monteleone, P., & Maj, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.360 · Cited by 51
Jackson, C., Kerssens, J. J., Fleetwood, K., Smıth, D. J., Mercer, S. W., & Wild, S. H. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.250 · Cited by 52
Drăgoi, A. M., Rădulescu, I. D., Pop, A. L., Năsui, B. A., Varlas, V. N., & Trifu, S. C. (2020) · Brain Sciences · doi:10.3390/brainsci10110840 · Cited by 48
Misiak, B., Łaczmański, Ł., Słoka, N. K., Szmida, E., Piotrowski, P., Loska, O., Ślężak, R., Kiejna, A., & Frydecka, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.077 · Cited by 48
Factors and their weight in reducing life expectancy in schizophrenia
Correll, C. U., Bitter, I., Hoti, F. J., Mehtälä, J., Wooller, A., Pungor, K., & Tiihonen, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.10.019 · Cited by 44
Talaslahti, T., Alanen, H., Hakko, H. H., Isohanni, M. K., Häkkinen, U., & Leinonen, E. V. J. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4159 · Cited by 43
Ribe, A. R., Vestergaard, M., Katon, W. J., Charles, M., Benros, M. E., Vanderlip, E. R., Nordentoft, M., & Laursen, T. M. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14091100 · Cited by 43
Self-citationCoello, K., Kjærstad, H. L., Stanislaus, S., Melbye, S. A., Faurholt‐Jepsen, M., Miskowiak, K. W., McIntyre, R. S., Vinberg, M., Kessing, L. V., & Munkholm, K. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418815987 · Cited by 44
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Singh, R., Stogios, N., Smith, E., Lee, J., Maksyutynska, K., Au, E., Wright, D. C., Palma, G. D., Graff‐Guerrero, A., Gerretsen, P., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221096525 · Cited by 44
General Medical Outcomes From the Primary and Behavioral Health Care Integration Grant Program
Scharf, D. M., Hackbarth, N. S., Eberhart, N. K., Horvitz-Lennon, M. V., Beckman, R., Han, B., Pincus, H. A., & Burnam, M. A. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201500352 · Cited by 43
Why are somatic diseases in bipolar disorder insufficiently treated?
Nielsen, R. E., Kugathasan, P., Straszek, S. P. V., Jensen, S. E., & Licht, R. W. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0147-y · Cited by 44
Neurological Disorders and Risk of Arrhythmia
Bernardi, J., Aromolaran, K. A., & Aromolaran, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010188 · Cited by 40
Deenik, J., Tenback, D. E., Tak, E. C. P. M., Hendriksen, I. J. M., & van Harten, P. N. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.10.004 · Cited by 39
Beunders, A. J. M., Orhan, M., & Dols, A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000883 · Cited by 39
Bartlem, K. M., Bowman, J., Freund, M., Wye, P. M., Lecathelinais, C., McElwaine, K., Wolfenden, L., Gillham, K. E., & Wiggers, J. H. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400360 · Cited by 39
DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2015) · Epigenomics · doi:10.2217/epi.15.5 · Cited by 39
Bailey, J. M., Bartlem, K. M., Wiggers, J., Wye, P. M., Stockings, E., Hodder, R. K., Metse, A. P., Regan, T. W., Clancy, R., Dray, J., et al. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.100969 · Cited by 41
Suetani, S., Rosenbaum, S., Scott, J. G., Curtis, J., & Ward, P. B. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001043 · Cited by 37
Management of serious cardiac adverse effects of antipsychotic medications
Stoner, S. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.11.246 · Cited by 37
Solmi, M., Koyanagi, A., Thompson, T., Fornaro, M., Correll, C. U., & Veronese, N. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579601800077x · Cited by 36
Hastrup, L. H., Simonsen, E. H., Ibsen, R., Kjellberg, J., & Jennum, P. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz041 · Cited by 36
Central levels of tryptophan metabolites in subjects with bipolar disorder
Trepci, A., Sellgren, C. M., Pålsson, E., Brundin, L., Khanlarkhani, N., Schwieler, L., Landén, M., & Erhardt, S. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.018 · Cited by 36
Gene‐specific DNA methylation may mediate atypical antipsychotic‐induced insulin resistance
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12422 · Cited by 36
An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder
Burghardt, K. J., Evans, S. J., Wiese, K. M., & Ellingrod, V. L. (2015) · Clinical and Translational Science · doi:10.1111/cts.12324 · Cited by 35
Dalton, S. O., Suppli, N. P., Ewertz, M., Kroman, N. T., Grassi, L. G., & Johansen, C. (2018) · The Breast · doi:10.1016/j.breast.2018.06.002 · Cited by 35
Quality of life and clinical outcomes in bipolar disorder: An 8-year longitudinal study
Khafif, T. C., Belizário, G. O., Silva, M., Gomes, B. C., & Lafer, B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.061 · Cited by 35
Hindley, G., Stephenson, L., Keene, A. R., Rifkin, L., Gergel, T., & Owen, G. S. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14989.2 · Cited by 35
Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning
Hansen, L., Bernstorff, M., Enevoldsen, K., Kolding, S., Damgaard, J. G., Perfalk, E., Nielbo, K. L., Danielsen, A. A., & Østergaard, S. D. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4702 · Cited by 34
Hällgren, J., Ösby, U., Westman, J., & Gissler, M. (2018) · Scandinavian Journal of Public Health · doi:10.1177/1403494818758912 · Cited by 36
Self-citationKugathasan, P., Wu, H., Gaughran, F., Nielsen, R. E., Pritchard, M., Dobson, R., Stewart, R. J., & Stubbs, B. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.061 · Cited by 34
Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine
Falkai, P., Schmitt, A., Rosenbeiger, C. P., Maurus, I., Hattenkofer, L., Hasan, A., Malchow, B., Heim-Ohmayer, P., Halle, M., & Heitkamp, M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01360-x · Cited by 40
Darke, S. G., Marel, C., Mills, K. L., Ross, J. E., Slade, T. N., & Teesson, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.010 · Cited by 33
Treatment following myocardial infarction in patients with schizophrenia
Attar, R., Johansen, M. B., Valentin, J. B., Aagaard, J., & Jensen, S. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189289 · Cited by 33
Mohamed, M., Rashid, M. O., Farooq, S., Siddiqui, N., Parwani, P. J., Shiers, D., Thamman, R., Gulati, M., Shoaib, A., Chew-Graham, C. A., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.021 · Cited by 34
Ali, S., Santomauro, D. F., Ferrari, A. J., & Charlson, F. (2023) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796023000045 · Cited by 33
Mayeli, A., LaGoy, A. D., Smagula, S. F., Wilson, J. D., Zarbo, C., Rocchetti, M., Starace, F., Zamparini, M., Casiraghi, L., Calza, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02050-x · Cited by 33
Foroughi, M., Medina‐Inojosa, J. R., Lopez-Jimenez, F., Saeidifard, F., Suarez, L., Stokin, G. B., Prieto, M. L., Rocca, W. A., Frye, M. A., & Morgan, R. J. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001017 · Cited by 33
Increased long-term mortality after myocardial infarction in patients with schizophrenia
Kugathasan, P., Laursen, T. M., Grøntved, S., Jensen, S. E., Aagaard, J., & Nielsen, R. E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.015 · Cited by 32
Self-citationCuperfain, A. B., Kennedy, J. L., & Gonçalves, V. F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.022 · Cited by 32
Quality and Predictors of Diabetes Care Among Patients With Schizophrenia: A Danish Nationwide Study
Jørgensen, M., Mainz, J., Carinci, F., Thomsen, R. W., & Johnsen, S. P. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600460 · Cited by 31
Bartlem, K. M., Bowman, J., Freund, M., Wye, P. M., Barker, D., McElwaine, K., Wolfenden, L., Campbell, E. M., McElduff, P., Gillham, K. E., et al. (2015) · Implementation Science · doi:10.1186/s13012-016-0408-4 · Cited by 29
Walburg, F. S., van Meijel, B., Hoekstra, T., Kol, J., Pape, L. M., de Joode, J. W., van Tulder, M., & Adriaanse, M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1566 · Cited by 27
Metadata
- Authors
- Laursen, T. M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Nordentoft, M.
- Affiliations
- Aarhus University (DK)
- Finnish Institute for Health and Welfare (FI)
- Karolinska Institutet (SE)
- University of Copenhagen (DK)
- Corresponding author
- Laursen, Thomas Munk
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-06-24
- Volume
- 8
- Issue
- 6
- Pages
- e67133
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3691116
- OpenAlex
- W2063598898
- Semantic Scholar
- 6de46ba13d1d5cdb71f0637d20707d4c3c6bde53
- Cited by
- 313
- References
- 43
- Citations by year
- 2026: 16 · 2025: 9 · 2024: 24 · 2023: 23 · 2022: 24 · 2021: 28 · 2020: 24 · 2019: 37 · 2018: 28 · 2017: 31 · 2016: 31 · 2015: 19 · 2014: 18 · 2013: 1
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Stanley Medical Research Institute
- Lundbeckfonden (R155-2012-11280)
- H. Lundbeck A/S
- Medical Research Council (MR/K006525/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar disorder, schizophrenia, circulatory diseases, cardiovascular mortality, excess mortality, life expectancy, standardized mortality ratio, mental illness, Nordic countries, Denmark, Sweden, Finland
- MeSH terms
- Bipolar Disorder, Cardiovascular Diseases, Cardiovascular System, Cause of Death, Female, Humans, Life Expectancy, Male, Scandinavian and Nordic Countries, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
